401 related articles for article (PubMed ID: 26759315)
1. Frequency of level II and III axillary nodes metastases in patients with positive sentinel lymph nodes in melanoma: a multi-institutional study in Japan.
Tsutsumida A; Takahashi A; Namikawa K; Yamazaki N; Uhara H; Teramoto Y; Takenouchi T; Fukushima S; Yokota K; Uehara J; Matsushita S; Shibayama Y; Hatta N; Masui Y; Uchi H; Fujisawa Y; Ogata D
Int J Clin Oncol; 2016 Aug; 21(4):796-800. PubMed ID: 26759315
[TBL] [Abstract][Full Text] [Related]
2. Is a level III dissection necessary for a positive sentinel lymph node in melanoma?
Namm JP; Chang AE; Cimmino VM; Rees RS; Johnson TM; Sabel MS
J Surg Oncol; 2012 Mar; 105(3):225-8. PubMed ID: 21882199
[TBL] [Abstract][Full Text] [Related]
3. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
[TBL] [Abstract][Full Text] [Related]
4. Epitrochlear sentinel lymph nodes in melanoma: interval or independent?
Kidner TB; Yoon JL; Faries MB; Morton DL
Am Surg; 2012 Jun; 78(6):702-5. PubMed ID: 22643268
[TBL] [Abstract][Full Text] [Related]
5. Utility of Level III Axillary Node Dissection in Melanoma Patients with Palpable Axillary Lymph Node Disease.
Mahvi DA; Fairweather M; Yoon CH; Cho NL
Ann Surg Oncol; 2019 Sep; 26(9):2846-2854. PubMed ID: 31209665
[TBL] [Abstract][Full Text] [Related]
6. Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases.
Mamtani A; Patil S; Van Zee KJ; Cody HS; Pilewskie M; Barrio AV; Heerdt AS; Morrow M
Ann Surg Oncol; 2016 Oct; 23(11):3481-3486. PubMed ID: 27169771
[TBL] [Abstract][Full Text] [Related]
7. Gamma probe-directed lymphatic mapping and sentinel lymphadenectomy in primary melanoma: Reliability of the procedure and analysis of failures after long-term follow-up.
Jacobs IA; Chevinsky AH; Swayne LC; Magidson JG; Britto EJ; Smith TJ
J Surg Oncol; 2001 Jul; 77(3):157-64. PubMed ID: 11455551
[TBL] [Abstract][Full Text] [Related]
8. How often do level III nodes bear melanoma metastases and does it affect patient outcomes?
Nessim C; Law C; McConnell Y; Shachar S; McKinnon G; Wright F
Ann Surg Oncol; 2013 Jun; 20(6):2056-64. PubMed ID: 23370671
[TBL] [Abstract][Full Text] [Related]
9. Role of number of sentinel nodes in predicting non-sentinel node metastasis in breast cancer.
Dong LF; Xu SY; Long JP; Wan F; Chen YD
J Int Med Res; 2018 Feb; 46(2):828-835. PubMed ID: 29441833
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
Eggermont AM
Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of sentinel lymph node biopsy prior to axillary lymph node dissection: the role of isolated tumor cells/micrometastases and multifocality/multicentricity-a retrospective study of 1214 breast cancer patients.
Schröder L; Fricker R; Stein RG; Rink T; Fitz H; Blasius S; Wöckel A; Müller T
Arch Gynecol Obstet; 2018 Jun; 297(6):1509-1515. PubMed ID: 29594495
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study.
Classe JM; Loaec C; Gimbergues P; Alran S; de Lara CT; Dupre PF; Rouzier R; Faure C; Paillocher N; Chauvet MP; Houvenaeghel G; Gutowski M; De Blay P; Verhaeghe JL; Barranger E; Lefebvre C; Ngo C; Ferron G; Palpacuer C; Campion L
Breast Cancer Res Treat; 2019 Jan; 173(2):343-352. PubMed ID: 30343457
[TBL] [Abstract][Full Text] [Related]
13. Complete lymph node dissection or observation in melanoma patients with multiple positive sentinel lymph nodes: A single-center retrospective analysis.
Persa OD; Knuever J; Mauch C; Schlaak M
J Dermatol; 2018 Oct; 45(10):1191-1194. PubMed ID: 30095864
[TBL] [Abstract][Full Text] [Related]
14. Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study.
Mozzillo N; Pasquali S; Santinami M; Testori A; Di Marzo M; Crispo A; Patuzzo R; Verrecchia F; Botti G; Montella M; Rossi CR; Caracò C
Eur J Surg Oncol; 2015 Jul; 41(7):823-9. PubMed ID: 25800935
[TBL] [Abstract][Full Text] [Related]
15. Independent risk factors for axillary lymph node metastasis in breast cancer patients with one or two positive sentinel lymph nodes.
Zhang W; Xu J; Wang K; Tang XJ; Liang H; He JJ
BMC Womens Health; 2020 Jul; 20(1):143. PubMed ID: 32646416
[TBL] [Abstract][Full Text] [Related]
16. The evolution of the sentinel node procedure in the treatment of breast cancer.
Tvedskov TF
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
[TBL] [Abstract][Full Text] [Related]
17. Is completion lymphadenectomy after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary?
Elias N; Tanabe KK; Sober AJ; Gadd MA; Mihm MC; Goodspeed B; Cosimi AB
Arch Surg; 2004 Apr; 139(4):400-4; discussion 404-5. PubMed ID: 15078708
[TBL] [Abstract][Full Text] [Related]
18. The intraoperative assessment of sentinel nodes - Standards and controversies.
van der Noordaa MEM; Vrancken Peeters MTFD; Rutgers EJT
Breast; 2017 Aug; 34 Suppl 1():S64-S69. PubMed ID: 28673534
[TBL] [Abstract][Full Text] [Related]
19. Role of frozen section in sentinel lymph node biopsy for breast cancer in the era of the ACOSOG Z0011 and IBCSG 23-10 trials.
Lombardi A; Nigri G; Maggi S; Stanzani G; Vitale V; Vecchione A; Nania A; Amanti C
Surgeon; 2018 Aug; 16(4):232-236. PubMed ID: 29329752
[TBL] [Abstract][Full Text] [Related]
20. Axillary Lymph Node Metastases of Melanoma: Management of Third-level Nodes.
Gentile D; Covarelli P; Picciotto F; Caliendo V; Stingeni L; Del Sordo R; Rulli A
In Vivo; 2016; 30(2):141-5. PubMed ID: 26912825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]